Community Healthcare Trust Inc CHCT
We take great care to ensure that the data presented and summarized in this overview for Community Healthcare Trust Inc is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding CHCT
View all-
Black Rock Inc. New York, NY4.67MShares$83.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.76MShares$49.6 Million0.0% of portfolio
-
Macquarie Group LTD Australia, C31.22MShares$21.9 Million0.02% of portfolio
-
Systematic Financial Management LP Teaneck, NJ937KShares$16.8 Million0.45% of portfolio
-
State Street Corp Boston, MA935KShares$16.8 Million0.0% of portfolio
-
Aristotle Capital Boston, LLC Boston, MA789KShares$14.1 Million0.49% of portfolio
-
Geode Capital Management, LLC Boston, MA675KShares$12.1 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny625KShares$11.2 Million0.01% of portfolio
-
Balyasny Asset Management LLC Chicago, IL599KShares$10.8 Million0.02% of portfolio
-
Kennedy Capital Management, Inc. St Louis, MO582KShares$10.4 Million0.25% of portfolio
Latest Institutional Activity in CHCT
Top Purchases
Top Sells
About CHCT
Community Healthcare Trust Incorporated is a real estate investment trust that focuses on owning income-producing real estate properties associated primarily with the delivery of outpatient healthcare services in our target sub-markets throughout the United States. The Company had investments of approximately $667.3 million in 131 real estate properties as of September 30, 2020, located in 33 states, totaling approximately 2.8 million square feet.
Insider Transactions at CHCT
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Sep 09
2024
|
R. Lawrence Van Horn Director |
BUY
Open market or private purchase
|
Direct |
10,000
+13.84%
|
$160,000
$16.13 P/Share
|
Aug 19
2024
|
Leigh Ann Stach Executive Vice President & CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,081
-0.99%
|
$73,458
$18.56 P/Share
|
Aug 13
2024
|
Cathrine Cotman Director |
BUY
Open market or private purchase
|
Direct |
2,000
+8.75%
|
$34,000
$17.72 P/Share
|
Aug 08
2024
|
Leigh Ann Stach Executive Vice President & CAO |
BUY
Grant, award, or other acquisition
|
Direct |
40,440
+8.94%
|
$889,680
$22.73 P/Share
|
Aug 08
2024
|
William G. Iv Monroe Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
43,502
+27.03%
|
$957,044
$22.73 P/Share
|
Aug 08
2024
|
Timothy L. Meyer EVP - Asset Management |
BUY
Grant, award, or other acquisition
|
Direct |
30,776
+14.29%
|
$677,072
$22.73 P/Share
|
Aug 08
2024
|
David H. Dupuy CEO and President |
BUY
Grant, award, or other acquisition
|
Direct |
58,660
+12.2%
|
$1,290,520
$22.73 P/Share
|
Aug 05
2024
|
Robert Z Hensley Director |
BUY
Open market or private purchase
|
Direct |
6,500
+8.42%
|
$123,500
$19.5 P/Share
|
Aug 05
2024
|
David H. Dupuy CEO and President |
BUY
Open market or private purchase
|
Direct |
10,000
+2.68%
|
$190,000
$19.48 P/Share
|
Aug 05
2024
|
R. Lawrence Van Horn Director |
BUY
Open market or private purchase
|
Direct |
2,500
+4.57%
|
$47,500
$19.42 P/Share
|
Jul 01
2024
|
Timothy L. Meyer EVP - Asset Management |
SELL
Payment of exercise price or tax liability
|
Direct |
405
-0.26%
|
$9,315
$23.22 P/Share
|
Jul 01
2024
|
William G. Iv Monroe Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
641
-0.86%
|
$14,743
$23.22 P/Share
|
Jul 01
2024
|
Leigh Ann Stach Executive Vice President & CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
604
-0.16%
|
$13,892
$23.22 P/Share
|
Jul 01
2024
|
David H. Dupuy CEO and President |
SELL
Payment of exercise price or tax liability
|
Direct |
1,051
-0.3%
|
$24,173
$23.22 P/Share
|
Jun 03
2024
|
William G. Iv Monroe Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,000
+8.58%
|
-
|
May 16
2024
|
Robert Z Hensley Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,285
+6.26%
|
$102,840
$24.27 P/Share
|
May 16
2024
|
R. Lawrence Van Horn Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,439
+9.86%
|
$130,536
$24.27 P/Share
|
May 16
2024
|
Claire M Gulmi Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,439
+11.46%
|
$130,536
$24.27 P/Share
|
May 16
2024
|
Alan Gardner Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,439
+7.38%
|
$130,536
$24.27 P/Share
|
May 16
2024
|
Cathrine Cotman Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,285
+18.51%
|
$102,840
$24.27 P/Share
|
Last 12 Months Summary
Grant, award, or other acquisition | 330K shares |
---|---|
Open market or private purchase | 31K shares |
Payment of exercise price or tax liability | 10.6K shares |
---|